ZA200904148B - Pyrrolo [1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents - Google Patents

Pyrrolo [1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents

Info

Publication number
ZA200904148B
ZA200904148B ZA200904148A ZA200904148A ZA200904148B ZA 200904148 B ZA200904148 B ZA 200904148B ZA 200904148 A ZA200904148 A ZA 200904148A ZA 200904148 A ZA200904148 A ZA 200904148A ZA 200904148 B ZA200904148 B ZA 200904148B
Authority
ZA
South Africa
Prior art keywords
imidazoledione
pyrrolo
effective
treatment
chemotherapeutic agents
Prior art date
Application number
ZA200904148A
Other languages
English (en)
Inventor
Carlo Farina
Carla Ghelardini
Paola Petrillo
Original Assignee
Neurotune Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37882430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200904148(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Neurotune Ag filed Critical Neurotune Ag
Publication of ZA200904148B publication Critical patent/ZA200904148B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200904148A 2006-11-15 2009-06-12 Pyrrolo [1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents ZA200904148B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06124142A EP1925304A1 (en) 2006-11-15 2006-11-15 Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents

Publications (1)

Publication Number Publication Date
ZA200904148B true ZA200904148B (en) 2010-04-28

Family

ID=37882430

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904148A ZA200904148B (en) 2006-11-15 2009-06-12 Pyrrolo [1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents

Country Status (19)

Country Link
US (1) US7973066B2 (ja)
EP (2) EP1925304A1 (ja)
JP (1) JP2010509389A (ja)
CN (1) CN101605541A (ja)
AR (1) AR063819A1 (ja)
AT (1) ATE478668T1 (ja)
AU (1) AU2007321218A1 (ja)
BR (1) BRPI0718904A2 (ja)
CA (1) CA2669853A1 (ja)
CL (1) CL2007003281A1 (ja)
DE (1) DE602007008759D1 (ja)
EA (1) EA200900552A1 (ja)
ES (1) ES2347380T3 (ja)
IL (1) IL198689A0 (ja)
MX (1) MX2009005125A (ja)
NZ (1) NZ576995A (ja)
PE (1) PE20081494A1 (ja)
WO (1) WO2008058988A1 (ja)
ZA (1) ZA200904148B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,
US9125898B2 (en) 2008-11-14 2015-09-08 Neurotune Ag Acetam derivatives for pain relief
AU2015295507A1 (en) * 2014-07-31 2017-02-02 Glaxosmithkline Intellectual Property Development Limited Use of CXCR2 antagonists for the prevention and/or treatment of chemotherapy induced peripheral neuropathy (cipn)
US20220313649A1 (en) * 2019-09-02 2022-10-06 Syddansk Universitet P-gp inducers as protectors against chemotherapy-induced side effects, such as peripheral neuropathy (cipn) and hair loss

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,

Also Published As

Publication number Publication date
BRPI0718904A2 (pt) 2013-12-10
CN101605541A (zh) 2009-12-16
EP2094265A1 (en) 2009-09-02
PE20081494A1 (es) 2008-12-19
IL198689A0 (en) 2010-02-17
ATE478668T1 (de) 2010-09-15
EP1925304A1 (en) 2008-05-28
CA2669853A1 (en) 2008-05-22
NZ576995A (en) 2010-12-24
CL2007003281A1 (es) 2008-06-27
ES2347380T3 (es) 2010-10-28
EP2094265B1 (en) 2010-08-25
US7973066B2 (en) 2011-07-05
US20100062077A1 (en) 2010-03-11
EA200900552A1 (ru) 2009-10-30
DE602007008759D1 (de) 2010-10-07
MX2009005125A (es) 2009-11-02
WO2008058988A1 (en) 2008-05-22
AR063819A1 (es) 2009-02-18
JP2010509389A (ja) 2010-03-25
AU2007321218A1 (en) 2008-05-22

Similar Documents

Publication Publication Date Title
HK1251568A1 (zh) 2-氟基-n-甲基-4-[7-(喹啉-6-基甲基)-咪唑[1，2-b][1，2，4]三嗪-2-基]苯甲酰胺鹽和與其製造相關的步驟
HK1199874A1 (en) Spiro-oxindole compounds and their uses as therapeutic agents
IL186615A0 (en) Spiroheterocylic compounds and their uses as therapeutic agents
GB0410725D0 (en) Pyrrolobenzodiazepine therapeutic agents
HK1103730A1 (en) Pyrrolopyridine derivatives and their use as crth2antagonists
SI1978947T1 (sl) Nitrooksiderivati za uporabo pri zdravljenju mišičnih distrofij
EP1962961A4 (en) HALF-BODY: THERAPEUTIC AGENTS ACTIVATED BY DIMÉRIZATION
IL182261A0 (en) Therapeutic agents with decreased toxicity
IL178816A0 (en) The treatment of childhood asthma
ME01219B (me) Alfa-aminoamid derivati korisni u liječenju bolesti zavisnosti
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
HRP20130533T1 (en) Amorphous solid dispersions of 7-chloro-n,n, 5-trimethyl-4-oxo-3-phenyl-3, 5,-dihydro-4h-pyridazino[4,5-b]indole-1-acetamide
ZA200703478B (en) Therapeutic agents with decreased toxicity
ZA200902630B (en) Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-A]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-A]pyrimidin-6-one derivatives
ZA200904148B (en) Pyrrolo [1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents
IL198481A0 (en) Pyrrole derivatives, preparation use of the same in therapy
IL195949A0 (en) Use of derivatives of imidazo[1,2-a]pyridine-2-carboxamides in therapeutics
PL2059521T3 (pl) Pirazolo[1,5-A]pirymidyny,sposoby, zastosowanie i kompozycje
ZA200700630B (en) Triazolopyrimidine compounds and their use for controlling pathogenic fungi
IL179256A0 (en) Triazolopyrimidine compounds and their use for controlling pathogenic fungi
HU0400429D0 (en) Body spray
HK1125634A1 (en) Pharmaceutical for use in the treatment of ureterolithiasis
TJ20050863A (en) The way of narcotism treatment
GB0400724D0 (en) The body snugg